Clinical TrialsSearch results
Number of results: 189
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Clinical effect of luekotriene receptor antagonist on provocation symptom induced by Japanese cedar pollene antigen disc and grope for clinical marker of nasal obstraction
- Japanese cedar pollinosis
- Faculity of Medicine, University of Fukui
- 2008-10-01
Other
- A controlled ,Prospective Study of the Effects of statins on Progression of diabetic nephropathy
- diabetic nephropathy
- Fukuiken-Saiseikai Hospital
- 2009-02-22
Other
- A controlled ,Prospective Study of the Effects of statins on Progression of diabetic nephropathy
- diabetic nephropathy
- Fukuiken-Saiseikai Hospital
- 2009-03-14
Other
- An exploratory research for a case with peripheral artery disease as a complication of lumbar spinal canal stenosis.
- lumbar spinal canal stenosis
- Fukushima medical university school of medicine
- 2008-12-05
Recruiting
- Preventive effects of topical washing with miconazole nitratecontaining soap to diaper candidiasis
- diaper candidiasis
- Hasegawa Minoru
- 2021-02-16
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- Prospective study of high dose MTX with R-CHOP therapy for primary central nervous system lymphoma.
- Primary CNS lymphoma (CD20+ diffuse large B-cell lymphoma)
- Hematology and Immunology, Kanazawa Medical University
- 2008-09-01
Other
- Prospective clinical study of R-CMD therapy for indolent B-cell lymphoma and mantle cell lymphoma
- indolent B-cell lymphoma, mantle cell lymphoma
- Hematology and Immunology, Kanazawa Medical University
- 2008-09-01
Recruiting
- A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients With CD123-Positive Hematological Malignancies
- Hematological Malignancies
- Hibi Kazushige
- 2024-02-15